Evidence map›Paper›PMID 40969385›Full record

ReviewThe World Allergy Organization journal2025

Wildfire and asthma - The prospective interventions.

Xingxing Yuan, Liuxin Yang, Chaofan Li, Ousman Bajinka, Zhuying Li

Abstract readReview
In one paragraph

Review in The World Allergy Organization journal, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Xingxing YuanFirst Clinical Medical College, Heilongjiang University of Chinese Medicine, Harbin 150040, China.
Liuxin YangFirst Clinical Medical College, Heilongjiang University of Chinese Medicine, Harbin 150040, China.
Chaofan LiFirst Clinical Medical College, Heilongjiang University of Chinese Medicine, Harbin 150040, China.
Ousman BajinkaMedical Science and Technology Innovation Center, Shandong Key Laboratory of Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, China.
Zhuying LiDepartment of Respiratory, First Affiliated Hospital of Heilongjiang University of Chinese Medicine, Harbin, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The increasing global warming trend has led to a drier landscape, which has in turn resulted in an increased incidence of wildfires. The smoke emanating from these fires has consequences that extend beyond the loss of property. This comes with the wildfire season whose smoke emanations have implications beyond loss of property. Among the health concerns regarding wildfires and smoke are respiratory diseases, such as asthma. Asthma, as a heterogeneous disease, is directly linked to other types of smoke rather than cigarettes, traffic exhaust, and industrial chemicals. Wildfires have been shown to be associated with particulate matter that act as pollutants to human life. The unprecedented increase in emergency visits during wildfire seasons is of clinical significance for its association with asthma and other pulmonary disorders. Despite the efforts of wealthy communities or nations, which have faced episodes of wildfires in recent years, the most effective protocol is yet to be developed. Given the vulnerability of individuals, including asthmatics, to the smoke from wildfires, interventions should extend beyond emergency measures. This review aims to provide a comprehensive overview of the relationship between wildfires and asthma symptoms, exploring the underlying mechanisms both

Indexed as

AsthmaParticulate matterPublic healthRespiratory tract diseasesWildfire

Identifiers

PMID40969385
PMCPMC12441628

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.